The question isnt whether desensitization occurs, but how quickly every-other-day dosing slows the process compared to daily administration, and implementing 68 week washout periods allows receptor density to recover fully before subsequent cycles
Constitutive activity of glucagon receptor mutants
Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (vglut1)
CYP17 inhibitors for prostate cancer therapy
Regulatory agencies, including the US Food and Drug Administration, the European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency, require extensive Phase III clinical trials, immunogenicity assessments, and comprehensive Chemistry, Manufacturing, and Controls data before approving new GLP-1 therapies or label expansions